1American Cancer Society. Available from: http://www.cancer. org/doctor/home/index.asp.
2Anzick SL, Kononen J, Walker RL, et al. AIB 1, a steroid re- ceptor coactivator amplified in breast and ovarian cancer. Sci- ence 1997; 277:965-968.
3Cai D, Shames DS, Raso MG, et al. Steroid receptor coacti- vator-3 expression in lung cancer and its role in the regulation of cancer cell survival and proliferation. Cancer Res 2010; 7fl:6477-6485.
4Dihge L, Bendahl PO, Grabau D, et al. Epidermal growth fac- tor receptor (EGFR) and the estrogen receptor modulator am- plified in breast cancer (AIB 1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer. Breast Cancer Res Treat 2008; 109:255-262.
5Osborne CK, Bardou V, Hopp TA, et al. Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in ta- moxifen resistance in breast cancer. J Natl Cancer Inst 2003; 95:353-361.
6Chen HW, Lin RJ, Xie W, Wilpitz D, Evans RM. Regulation of hormone-induced histone hyperacetylation and gene acti- vation via acetylation of an acetylase. Cell 1999; 98:675-686.
7Feng Q, Yi P,-Wong JM, O'Malley BW. Signaling within a coactivator complex: methylation of SRC-3/AIB1 is a mo- lecular switch for complex disassembly. Mol Cell Biol 2006; 26:7846-7857.
8Wu RC, Qin J, Yi P, et al. Selective phosphorylations of the SRC-3/AIB 1 coactivator integrate genomic responses to mul- tiple cellular signaling pathways. Mol Cell 2004; 15:937-949.
10Mitchell RA, Liao H, Chesney J, et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate im- mune response, Proc NatlAcadSci USA 2002; 99:345-350.
